Nan Fung Group Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Hold |
102,984
| – | – | 3.5% | 11 |
|
|
2025
Q1 | $1.71M | Hold |
102,984
| – | – | 1.4% | 23 |
|
|
2024
Q4 | $1.89M | Hold |
102,984
| – | – | 1.62% | 20 |
|
|
2024
Q3 | $1.58M | Hold |
102,984
| – | – | 1.36% | 23 |
|
|
2024
Q2 | $1.67M | Hold |
102,984
| – | – | 1.79% | 19 |
|
|
2024
Q1 | $1.9M | Buy |
102,984
+73,000
| +243% | +$1.35M | 1.76% | 17 |
|
|
2023
Q4 | $939K | Hold |
29,984
| – | – | 0.58% | 23 |
|
|
2023
Q3 | $625K | Hold |
29,984
| – | – | 0.51% | 25 |
|
|
2023
Q2 | $718K | Hold |
29,984
| – | – | 0.46% | 26 |
|
|
2023
Q1 | $564K | Hold |
29,984
| – | – | 0.38% | 32 |
|
|
2022
Q4 | $477K | Hold |
29,984
| – | – | 0.33% | 30 |
|
|
2022
Q3 | $491K | Hold |
29,984
| – | – | 0.31% | 26 |
|
|
2022
Q2 | $422K | Hold |
29,984
| – | – | 0.29% | 27 |
|
|
2022
Q1 | $726K | Sell |
29,984
-5,051
| -14% | -$122K | 0.34% | 26 |
|
|
2021
Q4 | $818K | Buy |
+35,035
| New | +$818K | 0.24% | 29 |
|